Sort
82,697 grants matching “vaccine development”
Development of a Multi-species Vaccine for Prevention of Bacterial Otitis Media
$1,207,921Charles C. McOsker · Clarametyx Bioscience, Inc. · R44 · FY2022 · DC
COVID-19 testing in Underserved and Vulnerable Populations Receiving Care in San Diego Community Health Centers
$1,207,841Maria Elena Martinez · University Of California, San Diego · UH3 · FY2021 · CA
Studies of Receptor Interactions and Effects of Alarmins
$1,207,540Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,207,417Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,207,252Vanderbilt University · U01 · FY2002 · AI
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8461 UNDER
$1,206,941Daniel Sullivan · H. Lee Moffitt Cancer Ctr & Res Inst · N01 · FY2009 · CA
Non-Human Primate Core
$1,206,858Ivona Pandrea · University Of Pennsylvania · P01 · FY2013 · AI
TASK ORDER B-15: Model Development and Medical Countermeasure Evaluation
$1,206,643Anthony Griffiths · Boston University Medical Campus · N01 · FY2023 · AI
Antidotes to Anthrax Lethal Factor Intoxication
$1,206,265Alan Thomas Johnson · Panthera Biopharma, Llc · U01 · FY2011 · AI
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
$1,206,220Michael S. Diamond · Washington University · R01 · FY2021 · AI
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$1,206,058Wendy Prudhommeomeara · Duke University · R01 · FY2024 · AI
Malaria Pathogenesis and Human Immunity
$1,205,828Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Administration Core
$1,205,763Samuel I. Miller · University Of Washington · U54 · FY2009 · AI
Structure based design of trimer interface epitope focused universal influenza vaccines
$1,205,696James E Crowe · Vanderbilt University Medical Center · U01 · FY2024 · AI
Antigen Processing And Presentation In The Intestine
$1,205,659Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis
$1,205,608Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2021 · AI
Immunotherapeutics Against Arenaviruses
$1,205,553Robert F Garry · Scripps Research Institute, The · U19 · FY2017 · AI
Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1
$1,205,048Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2019 · AI
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
$1,204,933Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2025 · AI
DIALS: supporting structural biology through open source diffraction processing software
$1,204,713Aaron Samuel Brewster · University Of Calif-Lawrenc Berkeley Lab · R24 · FY2024 · GM
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER
$1,204,600Stanford University · U01 · FY2002 · AI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
$1,204,584J Brooks Jackson · Social And Scientific Systems, Inc. · U01 · FY2010 · AI
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,204,486Kenner Rice · National Institute On Drug Abuse · ZIA · FY2013 · DA
Integrative analysis and modeling of human immune responses and pathologies
$1,204,175John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Directing Tumor-specific T cells to Tumors
$1,204,070Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · CA